Sukrit Kanchanasurakit

Mr. Sukrit Kanchanasurakit

School of pharmaceutical science - University of Phayao
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
MBMontana Buntragulpoontawee
Montana Buntragulpoontawee
KCKe-Vin Chang
Ke-Vin Chang
TVTimporn Vitoonpong
Timporn Vitoonpong
SPSineenard Pornjaksawan
Sineenard Pornjaksawan
KKKittipong Kitisak
Kittipong Kitisak
SKSukrit Kanchanasurakit
Sukrit Kanchanasurakit
Background: Peripheral nerve entrapment syndromes commonly result in pain, discomfort, and ensuing sensory and motor impairment. Many conservative measures have been proposed as treatment, local injection being one of those measures. Now with high-resolution ultrasound, anatomical details can be visualized allowing diagnosis and more accurate injection treatment. Ultrasound-guided injection technique using a range of injectates to mechanically release and decompress the entrapped nerves has therefore developed called hydrodissection or perineural injection therapy. Several different injectates from normal saline, local anesthetics, corticosteroids, 5% dextrose in water (D5W), and platelet-rich plasma (PRP) are available and present clinical challenges when selecting agents regarding effectiveness and safety.Aims: To systematically search and summarize the clinical evidence and mechanism of different commonly used injectates for ultrasound-guided hydrodissection entrapment neuropathy treatment.Methods: Four databases, including PubMed, EMBASE, Scopus, and Cochrane were systematically searched from the inception of the database up to August 22, 2020. Studies evaluating the effectiveness and safety of different commonly used injectates for ultrasound-guided hydrodissection entrapment neuropathy treatment were included. Injectate efficacy presents clinical effects on pain intensity, clinical symptoms/function, and physical performance, electrodiagnostic findings, and nerve cross-sectional areas. Safety outcomes and mechanism of action of each injectate were also described.Results: From ten ultrasound-guided hydrodissection studies, nine studies were conducted in carpal tunnel syndrome and one study was performed in ulnar neuropathy at the elbow. All studies compared different interventions with different comparisons. Injectates included normal saline, D5W, corticosteroids, local anesthetics, hyaluronidase, and PRP. Five studies investigated PRP or PRP plus splinting comparisons. Both D5W and PRP showed a consistently favorable outcome than those in the control group or corticosteroids. The improved outcomes were also observed in comparison groups using injections with normal saline, local anesthetics, or corticosteroids, or splinting. No serious adverse events were reported. Local steroid injection side effects were reported in only one study.Conclusion: Ultrasound-guided hydrodissection is a safe and effective treatment for peripheral nerve entrapment. Injectate selection should be considered based on the injectate mechanism, effectiveness, and safety profile.

4 February 2021 in Tobacco Induced Diseases
Verified
Journal Article
Open access
AUAdinat Umnuaypornlert
Adinat Umnuaypornlert
SKSukrit Kanchanasurakit
Sukrit Kanchanasurakit
DIDon Eliseo Lucero-Prisno III
Don Eliseo Lucero-Prisno III
SSSurasak Saokaew
Surasak Saokaew
Introduction: COVID-19 has major effects on the clinical, humanistic and economic outcomes among patients, producing severe symptoms and death. Smoking has been reported as one of the factors that increases severity and mortality rate among COVID-19 patients. However, the effect of smoking on...

31 March 2020 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
SKSukrit Kanchanasurakit
Sukrit Kanchanasurakit
AAAimusa Arsu
Aimusa Arsu
WSWuttikorn Siriplabpla
Wuttikorn Siriplabpla
ADAcharaporn Duangjai
Acharaporn Duangjai
SSSurasak Saokaew
Surasak Saokaew
Sukrit Kanchanasurakit, Aimusa Arsu, Wuttikorn Siriplabpla, Acharaporn Duangjai, Surasak Saokaew. Kidney Research and Clinical Practice 2020;39:81-92. https://doi.org/10.23876/j.krcp.19.106

9 December 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
APAbhisit Prawang
Abhisit Prawang
NCNaphatsawan Chanjamlong
Naphatsawan Chanjamlong
WRWoranattha Rungwara
Woranattha Rungwara
WSWichai Santimaleeworagun
Wichai Santimaleeworagun
TPTaniya Paiboonvong
Taniya Paiboonvong
SKSukrit Kanchanasurakit
Sukrit Kanchanasurakit
Stenotrophomonas maltophilia is a multidrug-resistant bacterium that is difficult to treat in hospitals worldwide, leading to high mortality. Published data describing the use of monotherapy or combination therapy and which one is better is still unclear. We aimed to investigate the efficacy of monotherapy and combination therapy in the treatment of S. maltophilia infections. We performed a systematic review of combination therapy and additionally a systematic review and meta-analysis to determine the effects of monotherapy versus combination therapy on mortality in S. maltophilia infections. Electronic databases: Cochrane Library, PubMed, Embase, ClinicalTrials.gov, Scopus, and OpenGrey were accessed. Of the 5030 articles identified, 17 studies were included for a systematic review of combination therapy, of which 4 cohort studies were finally included for meta-analysis. We found there is a trend of favorable outcomes with respect to mortality in the use of combination therapy to treat complex or severe S. maltopholia infections. A meta-analysis of monotherapy showed a statistical significance in the decreasing rate of mortality in hospital-acquired pneumonia (hazard ratio 1.42; 95% confidence interval, 1.04–1.94) compared to combination therapy, but not significant in bacteremia (hazard ratio 0.76; 95% confidence interval, 0.18–3.18). Further studies should continue to explore this association.

30 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
ARAnchalee Rawangkan
Anchalee Rawangkan
KKKirati Kengkla
Kirati Kengkla
SKSukrit Kanchanasurakit
Sukrit Kanchanasurakit
ADAcharaporn Duangjai
Acharaporn Duangjai
SSSurasak Saokaew
Surasak Saokaew
Influenza is one of the most serious respiratory viral infections worldwide. Although several studies have reported that green tea catechins (GTCs) might prevent influenza virus infection, this remains controversial. We performed a systematic review and meta-analysis of eight studies with 5048 participants that examined the effect of GTC administration on influenza prevention. In a random-effects meta-analysis of five RCTs, 884 participants treated with GTCs showed statistically significant effects on the prevention of influenza infection compared to the control group (risk ratio (RR) 0.67, 95% CIs 0.51–0.89, p = 0.005) without evidence of heterogeneity (I2 = 0%, p = 0.629). Similarly, in three cohort studies with 2223 participants treated with GTCs, there were also statistically significant effects (RR 0.52, 95% CIs 0.35–0.77, p = 0.001) with very low evidence of heterogeneity (I2 = 3%, p = 0.358). Additionally, the overall effect in the subgroup analysis of gargling and orally ingested items (taking capsules and drinking) showed a pooled RR of 0.62 (95% CIs 0.49–0.77, p = 0.003) without heterogeneity (I2 = 0%, p = 0.554). There were no obvious publication biases (Egger’s test (p = 0.138) and Begg’s test (p = 0.103)). Our analysis suggests that green tea consumption is effective in the prophylaxis of influenza infections. To confirm the findings before implementation, longitudinal clinical trials with specific doses of green tea consumption are warranted.

17 January 2024 in Journal of Travel Medicine
Verified
Journal Article
Closed access
PDF file
Sakarn CharoensakulchaiSakarn Charoensakulchai
Sakarn Charoensakulchai
MOManasvin Onwan
Manasvin Onwan
SKSukrit Kanchanasurakit
Sukrit Kanchanasurakit
GFGerard Flaherty
Gerard Flaherty
WMWasin Matsee
Wasin Matsee
Background: Drug tourism reflects the expanding illicit drug market, posing health risks in unfamiliar travel settings. Existing knowledge specifically addressing substance use among international travellers is sparse and has not been reviewed to date. This review aimed to describe the recreational substance abuse in international travellers. Methods: A literature search was conducted on PubMed, Google Scholar and Scopus using keywords related to recreational substances and international travellers. A total of 11 021 articles were reviewed, charted and summarized for the evidence on prevalence, patterns and characteristics of substance abuse and their health- and non-health-related problems on international travellers. Results: A total of 58 articles were included. Most were cross-sectional studies and review articles. In total, 20 articles addressed the prevalence of substance abuse in travellers, 33 looked at characteristics and patterns of substance abuse in travellers and 39 investigated the health- and non-health-related problems from substance abuse. Estimated prevalence of recreational substances abuse varied from 0.7% to 55.0%. Rates of substances abuse were 9.45–34.5% for cannabis, 20.4–35.9% for alcohol intoxication, 2.82–40.5% for MDMA, 2–22.2% for cocaine, 2–15% for psychedelic agents and 2% for methamphetamine. The prevalence varied according to travellers’ characteristics and travel destinations. Direct health problems included neuropsychiatric problems. Indirect problems included accident and unintentional injuries, crime and violence, risky sexual behaviours and sexual violence and blood-borne infections. Non-health-related problems included air rage, deportation and violation of local laws. Conclusion: Substance abuse among international travellers is an underestimated problem that requires intervention. These findings emphasize the importance of addressing this issue to mitigate both health and well-being problems among travellers whilst promoting safer and more responsible travel experiences. In the context of travel health practices, practitioners should counsel travellers whose itineraries may include substance abuse, informing them about associated risks and consequences.